[1] |
Ezgu F. Inborn errors of metabolism[J]. Adv Clin Chem, 2016, 73: 195-250.
doi: 10.1016/bs.acc.2015.12.001
pmid: 26975974
|
[2] |
Sanderson S, Green A, Preece MA, et al. The incidence of inherited metabolic disorders in the West Midlands, UK[J]. Arch Dis Child, 2006, 91 (11): 896-899.
doi: 10.1136/adc.2005.091637
pmid: 16690699
|
[3] |
Joint WHO/FAO/UNU Expert Consultation. Protein and amino acid requirements in human nutrition[R]. World Health Organ Tech Rep Ser, 2007, 935: 1-265.
|
[4] |
Van Calcar SC, Sowa M, Rohr F, et al. Nutrition management guideline for very-long chain acyl-CoA dehydrogenase deficiency (VLCAD): an evidence- and consensus-based approach[J]. Mol Genet Metab, 2020, 131 (1-2): 23-37.
doi: 10.1016/j.ymgme.2020.10.001
pmid: 33093005
|
[5] |
Alfadhel M, Al-Thihli K, Moubayed H, et al. Drug treatment of inborn errors of metabolism: a systematic review[J]. Arch Dis Child, 2013, 98 (6):454-461.
doi: 10.1136/archdischild-2012-303131
pmid: 23532493
|
[6] |
Baumgartner MR, Horster F, Dionisi-Vici C, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia[J]. Orphanet J Rare Dis, 2014, 9: 130.
doi: 10.1186/s13023-014-0130-8
pmid: 25205257
|
[7] |
Jurecki E, Ueda, K, Frazier D, et al. Nutrition management guideline for propionic acidemia: an evidence- and consensus-based approach[J]. Mol Genet Metab, 2019, 126 (4): 341-354.
doi: S1096-7192(18)30342-1
pmid: 30879957
|
[8] |
Boy N, Muhlhausen C, Maier EM, et al. Proposed recom-mendations for diagnosing and managing individuals with glutaric aciduria type I: second revision[J]. J Inherit Metab Dis, 2017, 40 (1): 75-101.
doi: 10.1007/s10545-016-9999-9
|
[9] |
顾学范, 韩连书, 余永国. 中国新生儿遗传代谢病筛查现状及展[J]. 罕见病研究, 2022, 1(1): 13-19.
|
[10] |
Blackburn PR, Gass JM, Vairo FPE, et al. Maple syrup urine disease: mechanisms and management.[J]. Appl Clin Genet, 2017, 10: 57-66.
doi: 10.2147/TACG
|
[11] |
Frazier DM, Allgeier C, Homer C, et al. Nutrition mana-gement guideline for maple syrup urine disease: an evidence- and consensus-based approach[J]. Mol Genet Metab, 2014, 112 (3): 210-217.
doi: 10.1016/j.ymgme.2014.05.006
pmid: 24881969
|
[12] |
Strauss KA, Carson VJ, Soltys K, et al. Branched-chain alpha-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes[J]. Mol Genet Metab, 2020, 129 (3): 193-206.
doi: S1096-7192(19)31291-0
pmid: 31980395
|
[13] |
Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision[J]. J Inherit Metab Dis, 2019, 42 (6): 1192-1230.
doi: 10.1002/jimd.12100
pmid: 30982989
|
[14] |
中国医师协会医学遗传医师分会临床生化专业委员会, 中华医学会儿科学分会内分泌遗传代谢学组, 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组, 等. 中国尿素循环障碍诊断治疗和管理指南[J]. 中华儿科杂志, 2022, 60 (11): 1118-1126.
|
[15] |
中国妇幼保健协会出生缺陷防治与分子遗传分会, 中国妇幼保健协会儿童早期发展专业委员会, 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组, 等. 糖原累积病Ⅰa型的诊断治疗和预防专家共识[J]. 中国实用儿科杂志, 2022, 37 (9): 641-649.
|
[16] |
Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American college of medical genetics and genomics[J]. Genet Med, 2014, 16 (11): e1.
doi: 10.1038/gim.2014.128
pmid: 25356975
|
[17] |
Parikh S, Goldstein A, Koenig MK., et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society[J]. Genet Med, 2015, 17 (9): 689-701.
doi: 10.1038/gim.2014.177
pmid: 25503498
|
[18] |
Sue CM, Balasubramaniam S, Bratkovic D, et al. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the mitochondrial medicine society recommendations[J]. Intern Med J, 2022, 52 (1): 110-120.
doi: 10.1111/imj.v52.1
|